A clinical stage biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

"Allakos is committed to developing innovative therapies that transform patients’ lives.

We strive to understand the needs of patients and are committed to collaborating with patients, advocacy groups, and physicians to incorporate their perspectives and needs into our development programs."